CCN2 and ocular melanoma: TGF-β1, in the absence of OM exposure, also up-regulated CTGF expressions during the early (Figure 3F), mid-term (Figure 3G), and mature phases (Figure 3H) (early, 71%; mid-term 68%; and mature, 41%).